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ABSTRACT 
Dopamine (DA) neurotransmission, particularly the ventral tegmental area-nucleus accumbens (VTA-
NAcc) projection, underlies reward and aversion processing, and deficient DA function could underlie 
motivational impairments in psychiatric disorders. 6-hydroxydopamine (6-OHDA) injection is an 
established method for chronic DA depletion, principally applied in rat to study NAcc DA regulation of 
reward motivation. Given the increasing focus on studying environmental and genetic regulation of 
DA function in mouse models, it is important to establish the effects of 6-OHDA DA depletion in mice, 
in terms of reward and aversion processing. This mouse study investigated effects of 6-OHDA-
induced NAcc DA depletion using the operant behavioural test battery of progressive ratio schedule 
(PRS), learned non-reward (LNR), learned helplessness (LH), treadmill, and in addition Pavlovian fear 
conditioning. 6-OHDA NAcc DA depletion, confirmed by ex vivo HPLC-ED, reduced operant 
responding: for gustatory reward under effortful conditions in the PRS test; to a stimulus recently 
associated with gustatory non-reward in the LNR test; to escape footshock recently experienced as 
uncontrollable in the LH test; and to avoid footshock by physical effort in the treadmill test. Evidence 
for specificity of effects to NAcc DA was provided by lack of effect of medial prefrontal cortex DA 
depletion in the LNR and LH tests. These findings add significantly to the evidence that NAcc DA is a 
major regulator of behavioural responding, particularly at the motivational level, to both reward and 
aversion. They demonstrate the suitability of mouse models for translational study of causation and 
reversal of pathophysiological DA function underlying motivation psychopathologies.    
 
Key words: mouse; dopamine; nucleus accumbens; prefrontal cortex; reward; aversion; motivation; 
depression   
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INTRODUCTION 
Dopamine (DA) neurons with cell bodies in the ventral tegmental area (VTA) innervate several brain 
regions, and primary among these are the nucleus accumbens (NAcc), prefrontal cortex (PFC), 
amygdala and hippocampus (Lammel et al., 2008; Sesack and Grace, 2010). The NAcc is part of the 
ventral striatum and has extensive connectivity with other brain regions: in addition to the VTA input, 
it receives excitatory afferents from PFC and amygdala and inhibitory afferents from ventral pallidum 
(VP). Major projection regions of the NAcc include, reciprocally, VP and VTA (Sesack and Grace, 
2010). Nucleus accumbens DA signalling modulates behavioural responsiveness to stimuli in terms of 
stimulus-stimulus learning, response-stimulus (operant) learning, and the motivation underlying 
behaviour directed at positive and negative stimuli (Salamone and Correa, 2012; Wise, 2004). Altered 
processing of positive- and negative-valence stimuli is characteristic of various psychiatric disorders, 
including depression and schizophrenia (Eshel and Roiser, 2010; Wang et al., 2015). For example, low 
motivation for reward underlies the core loss-of-interest symptom in depression and the core 
negative symptoms in schizophrenia; low motivation to cope with aversive stimuli likely contributes 
to both the perceived loss of control underlying helplessness (Nunes et al., 2013; Pryce et al., 2011; 
Treadway and Zald, 2011) and to fatigue (Demyttenaere et al., 2005). In the research domain criteria 
(RDoC) framework for mental health research (Cuthbert and Insel, 2013), motivation for reward is a 
dimension in the domain Positive valence systems, and emotions to and motivations induced by 
aversive stimuli are dimensions in the domain Negative valence systems (Cuthbert and Insel, 2013). 
Integrating the evidence for the importance of DA in regulating motivation with that for motivation 
pathologies, reduced DA function has been hypothesized as a major pathophysiological factor in 
depression (Dunlop and Nemeroff, 2007) and negative symptomatology in schizophrenia (Whitton et 
al., 2015). For example, using functional magnetic resonance imaging, reduced activity in the ventral 
striatum when anticipating reward was observed in both depression and schizophrenia patients 
compared to healthy controls (Arrondo et al., 2015; Hagele et al., 2015).  
Animal studies are essential to increase understanding of contributions of DA to adaptive and 
disrupted processing of rewarding and aversive stimuli. Much of the evidence for the importance of 
NAcc DA function in the modulation of goal-directed behaviour has been obtained in loss-of-function 
experiments conducted in rats. Infusion of the monoamine neurotoxin 6-hydroxydopamine (6-OHDA) 
into the NAcc, leading to specific degeneration of DA fibre terminals (Stott and Barker, 2014), is the 
most established method (Aberman and Salamone, 1999). It has been primarily applied to study 
NAcc DA in the processing of gustatory reward stimuli. In rat, in a free-choice paradigm, NAcc DA 
depletion delays development of preference for sucrose solution relative to water (Martinez-
Hernandez et al., 2012). NAcc DA depletion impairs both the operant acquisition of response-
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outcome learning and the motivation to respond, with the latter effect being most pronounced when 
high effort is required (Aberman and Salamone, 1999). Such findings demonstrate that NAcc DA 
regulates the motivation for (“wanting”) sweet-tasting stimuli (Nunes et al., 2013). In contrast, NAcc 
DA does not regulate appetite for homeostatic dietary need (Cousins and Salamone, 1994) or 
hedonic responding to (“liking”) sweet stimuli (Smith et al., 2011). There is also interest in DA 
regulation of the motivation required under cognitively effortful conditions. For example, VTA DA 
projection to prefrontal cortex (PFC) has been proposed to maintain goal-directed behaviour when 
challenged by distracter stimuli (Cools et al., 2011; van Schouwenburg et al., 2010). Reversal learning 
involves changes in response-outcome contingency and requires inhibition of responding to a 
stimulus previously associated with reward i.e. inhibition of perseveration, and disinhibition of 
responding to a stimulus previously associated with non-reward i.e. suppression of learned 
irrelevance/non-reward. Serotonin in PFC inhibits perseveration in common marmoset (Clarke et al., 
2004), and glutamate within orbital PFC suppresses learned irrelevance in a reversal test that 
separates perseveration and learned non-reward, in rat (Tait and Brown, 2007). Recently, a learned 
non-reward (LNR) test was described for mouse, allowing for the specific study of operant 
responding to a stimulus that previously had a negative valence (non-reward) and now has a positive 
valence (reward) in the absence of perseveration (Nilsson et al., 2012).  
Nucleus accumbens DA also modulates goal-directed behaviour relative to unconditioned 
aversive stimuli. Dopamine is released acutely in the NAcc in response to electric footshock (Young et 
al., 1993) and social stress (Cabib and Puglisi-Allegra, 2012), for example. In the case of 
inescapable/uncontrollable stimuli, the initial increase in NAcc DA is followed by a decrease below 
pre-stress tonic levels (Cabib and Puglisi-Allegra, 2012). As with positive stimuli, NAcc DA appears to 
modulate both the response-outcome learning and motivational aspects of behaviour relative to 
aversive stimuli. In rat, depletion of NAcc DA leads to a deficit in operant lever pressing or two-way 
shuttling to avoid-escape footshock (McCullough et al., 1993; Wenzel et al., 2015). In DA-deficient 
mice in which DA expression could be reactivated region-specifically, restoration of DA signalling to 
both entire striatum and amygdala was necessary and sufficient to enable mice to learn two-way 
active avoidance (Darvas et al., 2011). Also in mice, DA depletion in VTA and substantia nigra pars 
compacta led to increased sensitivity to inescapable footshock, expressed as a response deficit in a 
lever-press escape test i.e. learned helplessness (Winter et al., 2007). With respect to aversive 
stimulus-stimulus learning, studied primarily using Pavlovian fear conditioning, conditioned stimuli 
(CS e.g. tone) that predict footshock stimulate DA release in the NAcc (Pezze and Feldon, 2004; 
Wenzel et al., 2015). Whether NAcc DA depletion affects CS fear conditioning or expression remains 
to be investigated (Pezze and Feldon, 2004).  
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The present study investigated the effects of NAcc DA depletion in a battery of behavioural 
tests for assessment of responding to positive- and negative-valence stimuli in mice. The tests used 
are given in Table 1, together with the outcome stimulus and type of effort required to attain it, as 
well as the mediating behavioural dimensions according to the terminology of the RDoC framework 
(Cuthbert and Insel, 2013). The first test was operant responding for gustatory reward on a 
progressive ratio schedule (PRS) of reinforcement (Ineichen et al., 2012). Mice learned the operant 
response-outcome association prior to 6-OHDA administration, so that effects of NAcc DA depletion 
on approach motivation under physical effort could be investigated per se (Table 1). The second test 
was responding to operant stimuli with changing association with gustatory reward in a learned non-
reward (LNR) test (Nilsson et al., 2012): mice were trained through a series of simple + LNR 
discrimination stages prior to 6-OHDA administration. Then the effects of NAcc DA depletion were 
investigated on a final simple + LNR discrimination stage, the latter providing a test of cognitive effort 
and the maintaining of approach motivation when the association between an operant stimulus and 
reward shifts from negative to positive (Table 1). The third test was a learned helplessness (LH) test 
(Pryce et al., 2012), conducted after NAcc DA depletion. Mice were pre-exposed to inescapable 
footshock, followed by a two-way footshock escape test. The latter provided a test of motivation to 
escape aversion (safety motivation) requiring physical effort and cognitive perception of response-
outcome contingency (Table 1). The fourth test was a treadmill running test (Azzinnari et al., 2014), 
conducted after NAcc DA depletion. Mice learned that forward movement on the treadmill resulted 
in operant avoiding or escaping of footshock, using a slow speed. In the subsequent test conducted 
at a higher speed, running time provided a measure of motivation to avoid-escape aversion (safety 
motivation) under physical effort (Table 1). Whilst behaviour in each of these four tests was 
motivated by different stimulus outcomes and required different forms and degrees of effort to 
attain that outcome, each was based on operant learning. In contrast, the fifth test was auditory CS-
footshock fear conditioning, based on stimulus-outcome (Pavlovian) learning (Table 1). The 
behavioural effects of 6-OHDA depletion of NAcc DA were investigated in each of these tests. In 
addition, because 6-OHDA infusion onto NAcc also resulted in DA depletion in PFC, and given the 
importance of PFC in regulating cognitive aspects of goal-directed behaviour, effects of 6-OHDA 
infusion onto PFC were also studied directly for specific tests. This was the case for the LNR test 
where re-learning operant stimulus valence was required, and for the LH test because the PFC is 
critical to processing stimulus control and loss thereof (Amat et al., 2008). To our knowledge, this is 
the first study of the effects of NAcc DA depletion in the PRS and CS fear conditioning tests in mice, 
and the first to investigate effects of NAcc DA depletion in the LNR test and the treadmill test in any 
species.   
     (TABLE 1 ABOUT HERE) 
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As noted above, rat 6-OHDA studies have contributed most to current understanding of DA 
regulation of behaviour. However, there is increasing emphasis on the mouse as a study species. For 
example, chronic social defeat stress in mice has been shown to reduce reward-directed behaviour 
(Chaudhury et al., 2013; Tye and Deisseroth, 2012) and safety motivation relative to aversive stimuli 
(Azzinnari et al., 2014), and optogenetics has been applied to stimulate VTA DA neurons and reverse 
some of these effects (Chaudhury et al., 2013; Tanaka et al., 2012; Tye et al., 2013). Many such 
mouse studies are being guided by extrapolation of the findings obtained with NAcc 6-OHDA DA 
depletion in rat. Therefore, it is important to establish the behavioural effects of 6-OHDA DA 
depletion in mouse per se. Given the putative importance of NAcc DA in modulating motivation 
relative to positive- and negative-valence stimuli and the prevalence of motivation pathologies in 
psychiatric disorders, operant behavioural tests of effortful motivation are of particular relevance.  
 
MATERIALS AND METHODS 
Animals 
The study was conducted with male C57BL/6J mice (Janvier Labs, Saint-Berthevin, France) aged 10 
weeks and weighting 26.1 ± 2.0 g at the time of surgery. Mice were maintained in pairs in type 2L 
cages and on a reversed 12:12 h light-dark cycle (lights off at 07:00 h) in an individually-ventilated 
caging system, with temperature at 20-22°C and humidity at 50-60%. The standard diet was 
complete pellet (Provimi, Kliba Ltd, Kaiseraugst, Switzerland) and water, both available continuously 
and ad libitum unless for experimental reasons as stated below. All procedures were conducted 
under a permit for animal experimentation (No. 170/2012) issued by the Veterinary Office, Zurich, 
Switzerland, in accordance with the Animal Protection Act (1978) Switzerland.  
 
Injection of 6-hydroxydopamine (6-OHDA) 
At 30 min prior to injection of 6-OHDA or vehicle, mice received i.p. injections of desipramine 
hydrochloride (35 mg/kg, Sigma-Aldrich) and escitalopram oxalate (5 mg/kg, H. Lundbeck A/S, Valby, 
Denmark) to block 6-OHDA uptake by noradrenaline and serotonin neurons, respectively (Tanaka et 
al., 2012; Thiele et al., 2012). Mice were anaesthetised with a cocktail of fentanyl 0.04 mg/kg, 
midazolam 4 mg/kg and medetomidine 0.4 mg/kg, i.p.. Using a stereotaxic frame (WPI, Berlin, 
Germany) and 10 µl syringe (NanoFil, WPI) equipped with a 33G needle (WPI), mice received bilateral 
injections of 6-OHDA hydrochloride (Sigma-Aldrich) or vehicle in NAcc, mPFC or caudate putamen 
(CPu). 6-OHDA was dissolved in 0.9% saline containing 0.02% ascorbic acid (AA). Coordinates, 
established using a mouse brain atlas (Franklin and Paxinos, 2008) and pilot injections of methylene 
blue, were, relative to bregma: for NAcc (shell/core) AP +2.0, ML ±0.7, DV -4.6 mm; for mPFC 
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(prelimbic/infralimbic/medial orbital) AP +2.4, ML ±0.3, DV -2.4 mm; for CPu AP +1.0, ML ±2.0, DV -
3.0 mm. Injection parameters for 6-OHDA were, for NAcc 1.5 µg or 2 µg/0.5 µl/2.5 min, for mPFC 1.5 
µg/0.2 µL/2 min, and for CPu 3.5 µg/1.0 µL/10 min, and the same volume and rate were used for 
respective vehicle injections (0.02 % AA in saline). The 6-OHDA amount and volume injected were 
adjusted according to region size and basal DA level (see Results). The needle was left in place for a 
further 3 min to allow tissue diffusion, before being retracted slowly. A period of 10-12 days, 
sufficient for mouse post-surgery recovery and for degeneration of DA fibres (Stott and Barker, 
2014), was allowed between injection and behavioural testing. Body weight was measured on days 1-
10 post-surgery.  
 
Behavioural testing 
Operant tests using gustatory reward stimuli 
 Apparatus. For the progressive ratio schedule (PRS) and learned non-reward (LNR) 
experiments, training and testing were conducted using operant chambers (TSE Systems GmbH, Bad 
Homburg, Germany) details of which are given elsewhere (Ineichen et al., 2012). Briefly, operant 
nose-poke ports detected mouse nose poke responses via an infra-red beam, and port position and 
number changed according to the test (PRS or LNR). Sugar pellets (14 mg, Dustless Precision Pellets, 
TSE Systems GmbH) were delivered singly into the feeder port, which was situated adjacent to the 
single nose-poke port in the PRS test and in the wall opposite the two nose-poke ports in the LNR 
test. Pellet delivery was signalled by a tone from a speaker. Pellet retrieval was detected via infra-red 
beam. 
 Restricted feeding protocol. For 5 days, daily body weight and food intake were measured to 
obtain mean baseline values per mouse. Beginning one week before and continuing during the 
operant training phases of the PRS and LNR experiments, mice were food restricted and kept at 90-
95% of their free-feeding (baseline) body weight, to ensure motivation for operant training.  
 
Progressive ratio schedule (PRS) test 
 Naive mice (N=24) were initially trained to nosepoke into a single port to obtain a sucrose 
pellet under a fixed ratio 1 (FR1) schedule. Mice required 8-12 sessions to achieve operant learning, 
defined as 2 consecutive sessions with ≥ 30 pellets earned at FR1. For PRS testing, mice were 
returned to 100 % baseline body weight; this was to reduce appetite and thereby increase test 
sensitivity to detecting motivation for the sweet taste rather than calorific content, of sucrose 
pellets. Mice were then given 3 sessions of PRS testing and the mean score of the last two sessions 
was used to counter-balance allocation to experimental groups, NAcc Vehicle vs 6-OHDA. The PRS 
test parameters were: required number of nose-pokes on first trial = 1, number of consecutive trials 
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for which the ratio remained constant = 5, and number of nose-pokes by which the ratio increased 
per increment = 3, e.g. reward ratio on trials 1-5 = 1 response, on trials 6-10 = 4, on trials 11-15 = 7, 
and on trial 16-20 = 10, and so on. The break point, i.e. minimum time without at least 1 response, 
that resulted in end of the session was 600 s, and maximum session duration was 40 min. After 
surgery + 10-12 days, mice, weighing 100 % baseline body weight (104 ± 3 %), were given the PRS 
test. The measures of interest were: cumulative number of pellets earned and ratio attained at 10, 
20, 30 and 40 min after test onset, overall mean time between collection of pellet n and the first 
operant response for pellet n+1 (post-reinforcement pause, PRP), and absolute peak response rate 
(PRR) calculated as the highest overall response rate within a ratio and expressed as responses/min 
(Bezzina et al., 2008). 
 
Learned non-reward (LNR) test 
 The LNR test was based on that described by (Nilsson et al., 2012). Naive mice, N=19 in NAcc 
experiment and N=25 in mPFC experiment, were kept at 90-95% baseline body weight throughout 
LNR testing. Details of operant training for this test are given in Supplementary Material. Briefly, mice 
were trained to initiate each trial by one nosepoke into the feeder port, which illuminated an 
operant nose-poke port in the opposite, stimulus wall; one response in the operant port activated 
signalled delivery of a sucrose pellet into the feeder port, which the mouse returned to and retrieved 
the pellet. The criterion for completion of training was 2 consecutive sessions with ≥ 49 pellets 
earned. There were three spatial locations (left, middle, right) in the stimulus wall. The first test stage 
was two-choice spatial discrimination (SD): following trial initiation, the subject had to choose 
between two operant nose-poke ports whilst a blank panel occupied the third location. A response in 
the correct operant port led to delivery of a sucrose pellet in the feeder port and an incorrect 
response led to a 5 s timeout. Mice were allowed 10 s to initiate a trial and 6 s to make a choice 
response. The SD stage consisted of 70 trials divided into seven 10-trial blocks; SD learning criterion 
was nine correct responses within any 10-trial block, and if the subject did not attain criterion the SD 
stage was repeated the next day. On the day after attaining SD criterion, the second stage, learned 
non-reward (LNR), was presented: the incorrect operant port location at SD became the correct port, 
the previously correct operant port was replaced by the blank panel, and the blank panel was 
replaced by an operant port that became the new incorrect port. Number of trials, times allowed for 
trial initiation and choice responding, and learning criterion were identical to those at the SD stage. 
At the LNR stage, the subject must overcome no reinforcement-avoid behaviour and acquire 
reinforcement-approach behaviour at the previously incorrect/now correct operant port, without 
possibility to perseverate at the previously correct port (Nilsson et al., 2012).  Measures of interest 
for SD and LNR were: omissions to initiate a trial (OIT), omissions to make a choice response (OR), 
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incorrect choice response (IR), the sum of OIT, OR and IR, referred to as total errors (TE), and correct 
choice responses (CR). Prior to 6-OHDA infusion, mice were tested on three stages of SD+LNR so that 
the effects of DA depletion could be assessed against a stable baseline of acquired SD and LNR 
behaviour. Between completion of LNR and the subsequent SD stage, mice were given one session 
with only the central operant port (re-baselining). Total errors in the third LNR stage were used to 
counter-balance allocation to Vehicle and 6-OHDA groups. After surgery + 10-12 days, mice, weighing 
90-95 % baseline body weight (Expt NAcc 92 ± 4 %; Expt mPFC 93 ± 5 %,) were tested on the fourth, 
test stage of SD+LNR. 
 
Operant tests using footshock aversive stimuli 
Learned helplessness (LH) test 
 The LH test was conducted using a fully-automated apparatus (Multi Conditioning System, 
TSE Systems GmbH, Bad-Homburg, Germany) details of which are given in (Pryce et al., 2012). Briefly, 
an arena was positioned on an electrifiable grid and contained a central divider with an opening 
(“gate”) via which mice could transfer from one side of the arena to the other. The test was based on 
the evidence that pre-exposure of mice to inescapable (uncontrollable) footshocks in this context 
leads to a subsequent deficit in two-way escape behaviour to the same stimulus in the same context, 
relative to mice pre-exposed to the same amount of escapable (controllable) footshock and to mice 
without footshock pre-exposure i.e. a validated specific LH effect (Pryce et al., 2012). In the present 
experiment, only the inescapable condition was used, to assess whether NAcc or mPFC DA depletion 
affected (1) responses to inescapable footshock and (2) responses to the shift from inescapable to 
escapable footshock. (Whether DA depletion effects were specific to pre-exposure to inescapable 
stimuli or also altered responses to pre-exposure to escapable stimuli was not tested.) Naive mice 
were allocated randomly to 6-OHDA and Vehicle groups (NAcc experiment N=27, mPFC experiment 
N=24). After surgery + 10-12 days (day 1), mice were placed in the arena for 15-min without 
footshock to habituate them to the two-way arena and assess locomotor activity (activity test). On 
days 2-4, Inescapable footshock exposure, mice received 24 inescapable footshock (IS) trials/day, at 
0.15 mA; footshock duration was variable, with mean of 3.5 s, 2.7 s and 3.3 s on days 2, 3 and 4, 
respectively (maximum per trial footshock duration was 5 s on each day); with a variable inter-trial 
interval (ITI) of 50 ± 40 s. On day 5, Escape test, mice received 30 escapable footshock (ES) trials at 
0.20 mA, maximum footshock duration of 5s/trial, and ITI 50 ± 40 s. The following measures were 
calculated for the Escape test: total escape failures, mean escape latency, mean locomotor activity 
during ITI (arbitrary units/min, a.u./min), mean % time spent freezing during ITI (freezing defined as 
zero a.u. moved for at least 2 s), and distance moved during footshock (footshock reactivity, a.u./s). 
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 In the activity test specifically, NAcc 6-OHDA mice exhibited decreased locomotion (see 
Results). In order to investigate whether this was associated with an anxiogenic effect of DA 
depletion in a novel environment, an additional experiment was conducted in which mice were first 
given an activity test in the two-way arena, on the following day received NAcc 6-OHDA (N=10) or 
Vehicle (N=10) infusion, and were then given further activity tests in the familiar arena at 14 and 15 
days post-surgery. Because NAcc 6-OHDA led to a moderate reduction in CPu DA in the learned 
helplessness experiment, an additional control experiment was conducted in which 6-OHDA (N=4) or 
Vehicle (N=5) was injected on the CPu and effects on behaviour in the activity test were assessed.  
 
Treadmill test 
 The same mice that were studied in terms of NAcc DA depletion effects in the LH test were 
used for this experiment, with an interval of 2 days. The treadmill test requires the mouse to run on 
an inclined (5°) plane to avoid or escape an electrified grid (Azzinnari et al., 2014). The test is suitable 
to detect changes in two states, although not concurrently: absolute level of effort to avoid-escape 
punishment - if this level is exceeded by the treadmill speed the subject will receive the maximum 
footshock amount shortly after test onset; cumulative level of effort to avoid-escape punishment - 
cumulative footshock will increase gradually but exponentially across time. On experimental day 1 
(training), mice were placed on the treadmill for 2 min at a speed of 0 cm/s, 5 min at 15-20 cm/s at 1 
min increments, and 5 min at 20 cm/s. Total number and duration of footshocks were scored 
automatically; maximum cumulative footshock duration was 20 s and training was terminated if this 
was reached. On day 2, a pre-test session consisted of 2 min at 0 cm/s and 5 min at 20 cm/s. This was 
followed immediately by the test session: 20 min at 23 cm/s, with the session stopped earlier if 
cumulative footshock duration reached 10 s. Test measures were running time at 23 cm/s (maximum 
20 min) and cumulative footshock duration (maximum 10 sec). 
 
Pavlovian CS-footshock fear conditioning test 
 For this test of aversive stimulus-stimulus conditioning the same apparatus was used as for 
the LH test. Naive mice (N=19) were allocated randomly to NAcc 6-OHDA and Vehicle groups. After 
surgery + 10-12 days (day 1), mice were placed on the grid in the arena (without central gate) for 15 
min without footshocks to assess locomotor activity and habituate mice to the arena (context). On 
day 2 (Conditioning) mice were placed back in the arena and exposed to 6 trials of 20 s tone (5 kHz, 
85 dB, conditioned stimulus, CS) the final 2 s of which were contiguous with an inescapable footshock 
of 0.20 mA (unconditioned stimulus, US) and with ITI of 120 s. On day 3 (Expression test) mice were 
returned to the arena for a 20-min context test (20 x 1-min bins), followed immediately by a CS test 
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in the same context comprising 12 x 30 s CS with ITI of 90 s. The test measure was % time spent 
freezing during CS or ITI trials (Cathomas et al., 2015; Fuertig et al., 2015). 
 
Hot plate pain test 
As an independent assessment of effects of NAcc DA depletion on pain sensitivity, a hot plate 
test was conducted in mice studied in the learned helplessness + treadmill experiment and in mice 
studied in the fear conditioning experiment, with an inter-test interval of 1 day. The hot plate test 
was conducted using a programmable thermoelectric heating plate (Teca, Chicago IL, USA) set at 
50°C (Pryce et al., 2012). The latency (s) until first occurrence of one of the following behaviours was 
scored: licking a forepaw, licking a hind paw, lifting a hind paw, jumping. The maximum test duration 
was 60 s. 
 
Ex vivo determination of brain tissue monoamine levels 
At 1-2 days after completion of a behavioural experiment, the fresh brain was collected, frozen on 
powdered dry-ice and stored at -80°C. Frozen brains were sectioned coronally at 1.0 mm intervals 
(Azzinnari et al., 2014). The NAcc, mPFC, CPu and amygdala (Amyg) were identified using a mouse 
brain atlas (Franklin and Paxinos, 2008) and micro-dissected bilaterally using a brain punch (Azzinnari 
et al., 2014) and the two punches per region were processed together. Mean total tissue weights per 
region were: NAcc = 1.7 mg, mPFC = 1.3 mg, CPu = 1.3 mg, Amyg = 1.6 mg.  
HPLC-ED for DA and 5-HT. For tissue homogenization, 100 µl (mPFC, Amyg), 250 µl (NAcc) or 
300 µl (CPu) ice-cooled perchloric acid (0.4 M) were added to each sample. Ultrasonication was 
conducted for 5 s at 30 % power (VibraCell, VCX130PB, Sonics and Materials, Newtown CT, USA), 
followed by centrifugation at 16,000×g for 10 min at 4°C. The supernatant was passed through a 0.22 
µm filter (Minisart RC4, Sartorius, Göttingen, Germany) and kept on ice until analysis. High 
performance liquid chromatography (HPLC) and electrochemical detection (ED) were conducted for 
DA and 5-HT and their respective major metabolites, dihydroxyphenylacetic acid (DOPAC) and 5-
hydroxyindoleacetic acid (5-HIAA), according to (Oeckl et al., 2012). Briefly, isocratic separation of DA 
and 5-HT was carried out with a reversed-phase C18 column (YMC-Pack ODS-AQ, 100×2.1 mm, S-3 
μm, YMC Europe). Homogenates (20 µl) were injected onto the HPLC system using an autosampler 
(ASI-100T). The mobile phase consisted of 1.7 mM 1-octanesulfonic acid sodium salt, 1.0 mM 
Na2EDTA × 2H2O, 8.0 mM NaCl, 100 mM NaH2PO4 × 2H2O (pH 3.8), mixed with 9.3% acetonitrile, and 
was delivered at a flow rate of 0.4 ml/min. For ED, an electrochemical flowcell with glassy carbon 
electrode and ISAAC Ag/AgCl reference electrode (VT-03 or SenCell, Antec) was used. Concentrations 
of monoamines and metabolites were calculated using external-standard calibration and expressed 
as ng/mg brain tissue. For the NAcc PRS and LNR experiments, the flowcell used was model VT-03, 
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and for all subsequent experiments the flowcell used was model SenCell. Nucleus accumbens DA 
concentrations obtained with the VT-03 were lower than those obtained with the SenCell and the 
latter also allowed for a lower limit of quantification (LLOQ) for DA, which was particularly important 
for mPFC samples (see Table 2). In the absence of any alternative explanation, it is possible that 
these differences between experiments were attributable to the flowcell used. 
 Radioenzymatic assay for noradrenaline. Following tissue homogenization (see above), NAcc, 
mPFC and Amyg samples were further diluted (1:10, 1:1 and 1:5, respectively) in artificial 
cerebrospinal fluid (aCSF). A radioenzymatic assay for NA was used, as described previously (Lu et al., 
2008). This assay involves COMT-catalyzed O-methylation using [3H]S-adenosylmethionine as methyl 
donor, and separation of the resulting [3H]normetanephrine by thin-layer chromatography (TLC).  
 
Immunohistochemistry for tyrosine hydroxylase 
In addition to HPLC-ED quantification of DA tissue levels, 6-OHDA depletion of DA fibre terminals in 
NAcc (and surrounding regions) was also assessed qualitatively using tyrosine hydroxylase 
immunohistochemistry. In an additional cohort of mice, following NAcc 6-OHDA (N=10) or Vehicle 
(N=10) infusion + 12 days, mice were deeply anaesthetized with pentobarbital and transcardially 
perfused with phosphate-buffered saline (PBS, pH 7.4) and fixative (4% paraformaldehyde (PFA) in 
PBS). Brains were post-fixed over-night in 4% PFA, and cryoprotected in 30% sucrose for 48h. Brains 
were frozen on powdered dry ice and cut at 40 µm with a microtome (Zeiss). Brain sections were 
collected in antifreeze solution and stored at -20°C until analysis. Free-floating sections were washed 
with PBS, quenched with 3% H2O2 for 15 min, blocked with normal goat serum and incubated o/n at 
4°C with a mouse anti-tyrosine hydroxylase antibody (1:1000; Santa Cruz Biotechnology), followed by 
2 h RT incubation with a biotinylated goat anti-mouse secondary antibody (1:500; Millipore). Sections 
were then incubated with 1% avidin-biotin peroxidase complex (Vectastain ABC kit, Vector) for 30 
min at RT. Staining was visualized using diaminobenzidine (DAB) solution. NAcc was identified using 
the mouse brain atlas (Franklin and Paxinos, 2008). Images were acquired using a brightfield 
microscope (Zeiss, Axiovert). 
 
Statistical analysis 
Statistical analysis of 6-OHDA lesion effects on behaviour and brain monoamine content was 
conducted using SPSS (version 20, SPSS Inc., Chicago IL, USA). In most cases an unpaired t-test was 
performed. Prior to conducting a t-test, Levene’s test for equality of variances was conducted; in case 
of non-equal variances the corresponding t-test was used and degrees of freedom adjusted 
accordingly. Analysis of variance (ANOVA) was conducted in cases of repeated measures, with a 
between-subject factor of group (6-OHDA, Vehicle) and a within-subject factor of test phase (e.g. PRS 
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test, LH test, fear conditioning test). Where appropriate, ANOVA post hoc testing was conducted 
using the Bonferroni procedure. Statistical significance was set at p≤0.05. Where an estimate of 
variance is given this is the standard deviation (SD). 
RESULTS 
Efficacy and specificity of 6-OHDA dopamine depletion 
The ex vivo DA tissue levels in NAcc, CPu, mPFC and Amyg are given in Table 2. In the five 
experiments in which 6-OHDA lesioning targeted NAcc, 6-OHDA induced a marked reduction in NAcc 
DA (mean per experiment = 74-87%). Off-target regions were selected for specificity control and 
because their DA function could be relevant to the behavioural processes under study. In CPu, DA 
was increased in the PRS test, decreased in the learned helplessness test + treadmill test, and 
unchanged in the other three experiments. In mPFC, where baseline (Vehicle) DA levels were 
markedly lower than in other regions, NAcc 6-OHDA reduced mPFC DA in each experiment. There 
was no effect of NAcc 6-OHDA on Amyg DA levels, as assessed in two experiments. In a control 
experiment in which 6-OHDA was injected onto CPu, it induced an almost complete (99%) depletion 
of CPu DA; there was no effect on DA in NAcc or Amyg whist DA was reduced in mPFC.  In the two 
experiments in which 6-OHDA lesioning targeted mPFC, 6-OHDA mice exhibited a marked reduction 
in mPFC DA (67-86%); DA depletion was specific to mPFC. Table 2 also provides the interval in days 
between 6-OHDA injection and brain collection for monoamine measurement. The interval was 
identical for all mice within each experiment, and varied between 11 and 24 days between 
experiments. There was no evidence that between-experiment differences in on-target or off-target 
effects on DA levels were due to the interval between 6-OHDA injection and brain collection. 
 With regards to 5-HT (Table S1), across all experiments there was only one region-specific 
case of decreased 5-HT and two region-specific cases of increased 5-HT, in 6-OHDA mice. To assess 
the effect of NAcc or mPFC 6-OHDA lesion on NA levels, additional experiments were conducted 
(Table S2): NAcc 6-OHDA lesion did not affect NA levels in any region; mPFC 6-OHDA lesion led to 
increased NA in the mPFC and decreased NA in the NAcc.  
     (TABLE 2 ABOUT HERE) 
 Nucleus accumbens 6-OHDA efficacy and specificity were also assessed qualitatively using 
tyrosine hydroxylase immunostaining of DA fibre terminals. Representative sections from Vehicle- 
and 6-OHDA-treated mice are given in Figure 1. In 6-OHDA mice, the tyrosine hydroxylase stain was 
markedly reduced in the medial-central core and the dorso-medial shell of NAcc in both 
hemispheres. One additional region that exhibited reduced staining in 6-OHDA mice was the extreme 
medial CPu. Of the ten 6-OHDA brains investigated, there were two cases where the tyrosine 
hydroxylase reduction was relatively small in the NAcc core-shell of one hemisphere.     
     (FIGURE 1 ABOUT HERE) 
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Physical effects of 6-OHDA dopamine depletion 
Effects of NAcc, CPu or mPFC 6-OHDA injection on body weight (BW) were measured for days 1 to 10 
after surgery. ANOVA was conducted for post-surgery BW expressed as a percentage of pre-surgery 
baseline (= 100%). Data for the NAcc learned helplessness + treadmill experiment are presented as a 
representative example of NAcc 6-OHDA experiments (Figure S1): There was a Group X Day (baseline, 
post-surgery days 1-10) interaction (F(10, 271)=4.3, p<0.0005); post hoc analysis revealed that Vehicle 
mice recovered to baseline BW by day 4 whereas 6-OHDA mice recovered by day 8 only, and that % 
BW was lower in 6-OHDA compared to Vehicle mice on days 1-5. For the CPu 6-OHDA control 
experiment, there was a main effect of Day (F(10, 70)=25.6, p<0.0005) but no effect involving Group 
(p≥0.87); post hoc analysis revealed that both groups recovered baseline BW by day 2 (data not 
shown). For the mPFC 6-OHDA learned helplessness experiment, there was a main effect of Day (F(10, 
220)=8.8, p<0.0005) but no effect involving Group (p≥0.56); post hoc analysis revealed that both 
groups recovered baseline BW by day 4 (data not shown). 
 In the following sections the behavioural effects of 6-OHDA injection on NAcc, CPu or mPFC 
in specific tests are reported. Whilst a number of interesting behavioural deficits were induced, the 
evidence indicates that these were absolute effects of DA reduction, and in 6-OHDA mice there was 
no evidence for significant correlation between the extent of depletion and the behavioural effect 
observed. 
 
Operant tests using gustatory reward stimuli 
Progressive ratio schedule (PRS) test 
In the PRS test, the effect of 1.5 or 2.0 µg 6-OHDA injection in the NAcc on reward motivation under 
effortful conditions was investigated. Following operant training and prior to surgery, mice were 
given three PRS tests, and for group allocation were counter-balanced on total number of pellets 
earned (Vehicle: 47.9 ± 0.3, 1.5 µg: 45.8 ± 0.3, 2 µg:  46.2 ± 0.8 (p=0.48)) and final ratio attained 
(Vehicle: 28.4 ± 0.4, 1.5 µg: 27.4 ± 0.4, 2 µg:  27.4 ± 1.0 (p=0.62)). For analysis of 6-OHDA effects on 
cumulative number of pellets earned and PR ratio attained, the PRS test was divided into four 10-min 
blocks and ANOVA was conducted for Dose X Time-block. For cumulative pellets earned there was a 
main effect of Dose (F(2, 21)=4.20, p<0.03; Fig. 2A); post hoc analysis revealed that mice injected with 2 
µg 6-OHDA earned less pellets than Vehicle mice (p<0.04). There was also a main effect of Dose for 
PR ratio attained (F(2, 21)=3.9, p<0.04; Fig. 2B); 2 µg 6-OHDA mice attained a lower ratio than Vehicle 
mice (p<0.04). The reduced motivation of NAcc DA-depleted mice was also evident in mean post-
reinforcement pause (PRP) (F(2, 21)=15.4, p<0.0005; Fig. 2C) with both 1.5 µg and 2 µg 6-OHDA mice 
exhibiting higher mean PRP than Vehicle mice, and in peak response rate (PRR) (F(2, 21)=3.5, p<0.05; 
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Fig. 2D) which was lower (and occurred at a lower ratio) in 2 µg 6-OHDA mice than in Vehicle mice. In 
all subsequent NAcc experiments, 2 µg 6-OHDA specifically was used. 
     (FIGURE 2 ABOUT HERE) 
Learned non-reward (LNR) test 
 The LNR test was used to investigate effects of 6-OHDA NAcc or mPFC injection on 
responding to operant stimuli with shifting association with gustatory reward. Mice were tested on 
three consecutive stages of both simple (SD) and learned non-reward (LNR) discrimination (SD+LNR 
1-3) prior to DA depletion, and therefore any effects of 6-OHDA could not be due to impaired 
operant task acquisition. In the NAcc experiment, task acquisition was indicated by improved 
performance across successive stages. For example, for total errors there was a main effect of Stage 
for both simple discrimination (F(2, 54) = 3.7, p<0.04) and learned non-reward (F(2, 38) = 4.0, p<0.03) (Fig. 
3A); the decrease in total errors across stages indicated that mice learned rule-switching (Nilsson et 
al., 2012; Tait and Brown, 2007). The total error scores at LNR3 were used to counterbalance 
allocation of mice to NAcc 6-OHDA and Vehicle groups. At the post-treatment simple discrimination 
stage (SD4), there was no effect of NAcc 6-OHDA on any measure, e.g. total errors (p=0.37, Fig. 3B). 
In contrast, NAcc 6-OHDA did impair behaviour at the post-treatment learned non-reward stage 
(LNR4) (Fig. 2B): relative to Vehicle mice, 6-OHDA mice exhibited increased omissions to initiate a 
trial (t(9.5) = -2.3, p<0.05), increased incorrect choice responses (t(17) = -3.2, p<0.005) and increased 
total errors (t(12.3) = -2.8, p<0.02). There was no effect on omissions to make a choice response (p<0.2) 
or correct choice responses (p<0.6). 
 In the mPFC experiment, as for NAcc, performance improved across successive stages of 
SD+LNR 1-3 testing, e.g. total errors decreased across stages of simple discrimination (F(2, 29) = 17.8, 
p<0.0005) and learned non-reward (F(2, 29) = 6.9, p<0.01). At the post-treatment simple discrimination 
stage (SD4) there was no effect of mPFC 6-OHDA on any measure (Table 3). In contrast to the NAcc 
experiment, there was also no effect of mPFC 6-OHDA on behaviour at the post-treatment learned 
non-reward stage (LNR4) (Table 3). 
     (FIGURE 3 ABOUT HERE) 
     (TABLE 3 ABOUT HERE) 
Operant tests using footshock aversive stimuli 
Learned helplessness (LH) test 
 The learned helplessness test was used to investigate effects of NAcc or mPFC 6-OHDA DA 
depletion on responsiveness to inescapable aversion and subsequent motivation to escape aversion 
(safety motivation) requiring physical effort and cognitive perception of response-outcome 
contingency. Following surgery and recovery, an activity test, three inescapable footshock pre-
exposure sessions and an escape test, were conducted on consecutive days. In the NAcc experiment, 
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in the activity test, 6-OHDA led to a decrease in locomotion (t(25) = 3.7, p<0.001, Fig. 4A) and an 
increase in % time freezing (Vehicle: 3.2 ± 1.5 %, 6-OHDA 6.3 ± 2.5 %, t(25) = -3.8, p<0.001). Mice were 
then exposed to three daily sessions of inescapable footshock: during the final session there was no 
effect of 6-OHDA on locomotor activity (Vehicle: 4617 ± 1148 a.u./min, 6-OHDA 3717 ± 1291 
a.u./min, p=0.08), but 6-OHDA mice did exhibit increased mean % time freezing (Vehicle: 10.8 ± 5.3 
%, 6-OHDA 18.7 ± 12.0 %, t(25) = 3.4, p<0.03). In the Escape test on the following day, there was no 
effect of 6-OHDA on locomotor activity (p=0.46, Fig. 4B) or % time freezing (Vehicle: 11.8 ± 5.3 %, 6-
OHDA 13.6 ± 7.9 %, p=0.49). There were effects of 6-OHDA in terms of an increased mean latency to 
escape (t(17.8) = -2.1, p<0.05, Fig. 4C) and increased number of escape failures (t(25) = -2.2, p<0.05, Fig. 
4D). Escape failures were also analysed in blocks of 10 trials to investigate for DA-depletion learning 
effects: there was a main effect of group (F(1, 25) = 4.6, p<0.05) and also of trial block (F(1, 50) = 4.4, 
p<0.02) but no interaction; whilst both 6-OHDA and Vehicle mice exhibited increased escape 
responses in trials 21-30 versus 1-10, indicating learning, the relative deficit in 6-OHDA mice 
persisted across the Escape test (Fig. 4E). The escape deficit in 6-OHDA mice co-occurred with 
decreased footshock reactivity (t(23) = 2.5, p<0.05, Fig. 4F, one outlier per group removed for 
analysis).   
     (FIGURE 4 ABOUT HERE) 
 We further investigated the findings of reduced locomotor activity and increased freezing by 
NAcc 6-OHDA mice in the activity test; this might indicate motor impairment or, given that the arena 
was novel during this session, increased anxiety/decreased motivation to explore novelty. An 
additional experiment (NAcc - Activity in Table 2) was conducted in which mice underwent an activity 
test prior to NAcc 6-OHDA lesion and were then re-tested in the familiar arena. Under these 
conditions there was no effect of NAcc 6-OHDA on locomotor activity (p=0.17, Fig. S2) or freezing 
(p=0.85), supporting the interpretation that NAcc 6-OHDA increased anxiety in/decreased motivation 
to explore the novel arena, rather than affecting locomotion per se.  
 Given that 6-OHDA mice in the NAcc - learned helplessness experiment exhibited a moderate 
decrease in CPu DA levels (Table 2), the effects of targeted CPu DA depletion in the activity test were 
studied in a separate cohort. An almost complete CPu DA depletion (CPu - Activity in Table 2) led to a 
40% decrease in locomotion (Vehicle: 8501 ± 1802 a.u./min, 6-OHDA 4825 ± 1558 a.u./min, p<0.01). 
This compared with a 25% decrease in locomotion in the activity test in NAcc 6-OHDA mice exhibiting 
the moderate off-target CPu DA effect and marked NAcc DA depletion (Fig. 4A).   
 In the mPFC experiment, in the activity test there was no effect of 6-OHDA on locomotor 
activity or % time freezing (Table 4). During the final session of inescapable footshock, there was 
again no effect on locomotor activity or % time freezing (Table 4). Also in the Escape test, mPFC DA 
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depletion was without any behavioural effects, on locomotor activity, mean % time freezing, escape 
failures, mean escape latency, or footshock reactivity. 
     (TABLE 4 ABOUT HERE)   
Treadmill test 
 In the treadmill test, using the same mice as studied in the learned helplessness paradigm 
two days previously, the effect of NAcc 6-OHDA injection on motivation to avoid-escape aversion 
(safety motivation) under physical effort was investigated. Mice were first exposed to the apparatus 
when it was stationary and then at walking speed, to enable them to acquire operant avoidance and 
escape responses. In the treadmill training session, there was no effect of 6-OHDA on total footshock 
time (p=0.44, Fig. 5A). The next day, during the 5-min pre-test session at a treadmill speed of 20 
cm/s, there was a borderline non-significant increase in total footshock time in 6-OHDA mice 
(Vehicle: 5.8 ± 8.4 s, 6-OHDA: 12.0 ± 8.3 s, p=0.06). In the treadmill test, conducted at a speed of 23 
cm/s, the running time achieved was decreased in 6-OHDA compared to Vehicle mice (t(25) = 3.7, 
p<0.001, Fig. 5B). Ten out of 13 Vehicle mice achieved the maximum running time of 20 min without 
accumulating 10 s of footshock, whereas this was the case in only 1 of 14 6-OHDA mice. Accordingly, 
total footshock time was higher in 6-OHDA than in Vehicle mice (t(21.4) = -4.1, p<0.001, Fig. 5C). 
     (FIGURE 5 ABOUT HERE) 
Pavlovian fear conditioning test 
 In the auditory tone-footshock (CS-US) fear conditioning test, the effects of NAcc 6-OHDA on 
aversive stimulus-stimulus fear learning, measured as % time spent freezing, were investigated. 
During the CS-US conditioning session, there was a main effect of CS trial-block on % time freezing 
(F(2, 34) = 23.9, p<0.0005, Fig. 6A), with acquired freezing increasing continuously across trials. There 
was no main or interaction effect of 6-OHDA (p=0.54, Fig. 6A). On the following day, consecutive 
expression tests were conducted for contextual and CS fear-freezing. There was no effect of NAcc 6-
OHDA on % time freezing in either the context test (p=0.32; Fig. 6B) or the CS test (p=0.51, Fig. 6C). 
Significant main effects of Trial in the context test (F(6, 102) = 14.0, p<0.0005, Fig. 6B) and CS trial in the 
CS test (F(5, 85) = 19.0, p<0.0005, Fig. 6C) indicated that freezing expression decreased as the test 
progressed, and that this occurred to a similar extent in 6-OHDA and Vehicle mice. 
     (FIGURE 6 ABOUT HERE) 
Hot plate test 
 Nucleus accumbens 6-OHDA injection resulted in reduced reactivity to footshock in the 
learned helplessness test and the treadmill test. One possible explanation for these effects is reduced 
motivation to escape-avoid and another is analgesia. Therefore, in mice that had been studied in the 
NAcc learned helplessness + treadmill experiment and the NAcc fear conditioning experiment, the 
hot plate test was carried out to assess thermal pain sensitivity. There was no effect of NAcc 6-OHDA 
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in mice studied in the learned helplessness test + treadmill test (response latency: Vehicle: 28.4 ± 
11.8 s, 6-OHDA: 26.6 ± 10.5 s, p=0.68) or in the fear conditioning test (Vehicle: 33.1 ± 11.0 s, 6-OHDA: 
27.5 ± 3.8 s, p=0.12). Also in mice that had been studied in the mPFC 6-OHDA - learned helplessness 
experiment, there was no effect of 6-OHDA injection (Vehicle: 24.8 ± 7.3 s, 6-OHDA: 22.8 ± 9.6 s, 
p=0.25). 
DISCUSSION 
The overall aim of the present study was to investigate the effects of substantive 6-OHDA-induced 
DA depletion in the nucleus accumbens on reward and punishment processing in a novel mouse 
operant test battery, with the emphasis on identifying deficits relevant to motivation pathologies in 
psychiatric disorders. Bilateral DA/DA fibre depletion in the nucleus accumbens resulted in 
decreased: responding for gustatory reward on an effortful operant schedule (PRS test); responding 
to an operant stimulus recently associated with non-reward (LNR test); two-way escape responding 
to an aversive stimulus that was recently uncontrollable (LH test); one-way active avoidance-escape 
responding to an aversive stimulus under effortful conditions (treadmill test). NAcc DA depletion was 
without effect on stimulus-outcome processing (fear conditioning test). Owing to co-administration 
of drugs blocking their respective transporter proteins, neither serotonin nor noradrenaline were 
depleted by NAcc 6-OHDA lesion, indicating that the observed effects were consequent to DA 
depletion. Whilst NAcc 6-OHDA injection also resulted in off-target mPFC DA depletion, direct mPFC 
DA depletion did not recapitulate the behavioural effects of NAcc DA depletion when investigated in 
the LNR test and LH test.  
 
Accumbens 6-OHDA lesioning impairs reward motivation under effortful or ambiguous conditions 
The progressive ratio schedule with gustatory reward has been applied previously to study 
effects of NAcc 6-OHDA lesioning in rat: reduced motivation was demonstrated for high-effort PR 
schedules specifically (Hamill et al., 1999). To our knowledge the present study provides the first 
demonstration that also in mice NAcc 6-OHDA reduces motivation for gustatory reward under the 
high-effort conditions of a PR schedule. These effects were to some extent 6-OHDA dose-dependent, 
and the higher, more efficacious dose of 2 µg per hemisphere was the specific dose used in all 
subsequent NAcc experiments. Mice were maintained at 100% baseline body weight (BW) for the 
PRS test, with the aim of maximising the palatable incentive value of sucrose pellets relative to their 
calorific value; rat studies also conducted PRS testing at or close to baseline BW e.g. (Hamill et al., 
1999). Given that mice received extensive operant training and three PRS sessions prior to DA 
depletion, it is clear that the deficits in DA-depleted mice were not due to impaired task acquisition. 
Our findings support the hypothesis that NAcc DA modulates specific motivational processes 
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underlying behaviour directed towards palatable reward (and probably also other reward 
categories), including behavioural activation, exertion of effort, appetitive behaviour, and sustained 
task engagement (Salamone and Correa, 2012). Sucrose (vs. water)-preference studies in rats 
demonstrate that NAcc DA depletion does not decrease reward wanting under non-effortful 
conditions (Berridge and Robinson, 1998). In human depression, patients do not differ from healthy 
controls in their reports of the intensity and pleasantness of sucrose (Dichter et al., 2010). However, 
using monetary reward, depressed patients exhibit reduced motivation to expend effort to obtain 
reward (Treadway et al., 2012). Given that mPFC DA was also decreased in the NAcc 6-OHDA-treated 
mice, and given that mPFC DA activity has been demonstrated to be associated with motivation for 
reward under effortful conditions (McGregor et al., 1996; Treadway et al., 2012), the observed effect 
cannot be attributed unequivocally to NAcc DA and future studies will be needed to clarify this.    
 The learned non-reward test deployed here was first described for mice, and relatively 
recently (Nilsson et al., 2012); the absolute and relative number of trials and errors to attain learning 
criteria at SD and LNR stages, as well as the rate of learning across stages, were similar in the present 
and original studies. Two-choice spatial discrimination (SD) requires acquisition of operant 
stimulus(OS)-reward (unconditioned stimulus, US) and OS-non-reward associations, and elicitation of 
appetitive and avoidance behaviours, respectively, by these two associations. The LNR contingency 
change requires relearning that the OS-non-reward association is now an OS-reward association and 
concomitant overcoming of avoidance due to learned non-reward (LNR). Accumbens 6-OHDA, 
administered after SD+LNR training, was without effect on both omission and commission errors 
during SD, indicating that the OS-US acquisitions and appropriate appetitive and avoidance 
behaviours were intact. At the LNR stage, NAcc 6-OHDA mice exhibited increases in both omission of 
trial initiations and commission of incorrect responses, each of which we interpret as indicative of 
excessive learned non-reward. That is, in the absence of normal NAcc DA levels, motivation - 
including behavioural activation, effort, approach – to engage with an OS with a recent association 
with non-reward was decreased. Mice received extensive operant training and three pre-depletion 
SD+LNR sessions, so the high LNR errors in DA-depleted mice were not due to impairment of task 
acquisition. In a rat study with a reversal learning (rather than LNR) test, DA depletion in dorsal 
striatum impaired reversal (O'Neill and Brown, 2007). Also in a rat reversal learning study, NAcc 
injection of D1R or D2R antagonist or D1R agonist were each without effect, and a D2R agonist 
impaired reversal learning (Haluk and Floresco, 2009). Excitotoxic lesion of the NAcc, particularly the 
core region, has been demonstrated to impair reversal between strategies and stimulus dimensions, 
as well as reversal between stimuli within a dimension; however, the use of excitotoxic lesion means 
that the observed effects cannot be attributed unequivocally to DA deficiency (Reading and Dunnett, 
1991). In the original mouse LNR study, systemic serotonin 2C receptor (5-HT2CR) antagonism 
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decreased LNR errors specifically (Nilsson et al., 2012). Given that 5-HT2CR antagonism increases 
mesocorticolimbic DA function (Di Matteo et al., 2001), this performance-enhancing effect is relevant 
to the current findings that NAcc DA depletion leads to performance deficiency. 
 The PFC is a major projection region of the NAcc and is also important in reversal learning 
and other forms of behavioural flexibility (Clarke et al., 2004). In rat, the orbital PFC is important in 
simple reversal learning and the medial PFC in reversal learning between stimulus dimensions 
(Brown and Bowman, 2002). In the present study, mPFC 6-OHDA was without effect on either SD or 
LNR. Blockade of D1R or D2R in mPFC in rat reduced behavioural flexibility; it acted primarily by 
increasing perseveration (Floresco et al., 2006), which is not tested in the LNR paradigm. It is 
therefore possible that in reversal learning tasks, mPFC mainly contributes to overcoming 
perseveration rather than to LNR (Allen and Leri, 2014; Son et al., 2013). Furthermore, 
neurotransmitters other than DA, in particular serotonin, may modulate mPFC-dependent cognitive 
flexibility (Clarke et al., 2004; van der Plasse and Feenstra, 2008). Taken together, the two mouse 
LNR experiments provide robust evidence that DA signalling in NAcc, and not in mPFC, is essential for 
adaptive motivation when the association between an operant stimulus and reward shifts from 
negative to positive.  
 
Accumbens 6-OHDA lesioning impairs aversion-safety motivation under previously uncontrollable or 
effortful conditions 
We established the learned helplessness effect paradigm for mice in order to have an 
objective test of aversive un/controllability for this species (Pryce et al., 2012). Following repeated 
sessions of matched escapable footshock (ES) or inescapable footshock (IS), when both groups are 
tested under ES conditions, IS mice exhibit more escape failures. This deficit in escape behaviour is 
underlain by decreased motor reactivity to the footshock, which we interpret as a motivational 
deficit, particularly given that pain sensitivity remains intact (Pryce et al., 2012). In the present study 
we restricted the experiment to the IS condition, and demonstrated that NAcc, but not mPFC, DA 
depletion resulted in increased escape failure concomitant with increased escape latency and 
decreased motor reactivity. In rat, 6-OHDA injection in the striatum led to increased operant escape 
failure in subjects exposed to IS, and the same effect was obtained when 6-OHDA was injected into 
the substantia nigra pars compacta (Winter et al., 2007). Also in rat, in the absence of prior IS, 6-
OHDA NAcc DA depletion decreased operant (lever press) escape-avoid behaviour; furthermore, in 
intact subjects, performing this operant behaviour led to increased NAcc DA release (McCullough et 
al., 1993). Rats exposed to IS and exhibiting a high level of 2-way escape failure were characterised 
by a decrease in the proportion of active DA neurons in the VTA (Belujon and Grace, 2015). 
Therefore, in addition to chronic NAcc DA depletion impairing motivational processes that mediate 
21 
 
engagement with reward, as evidenced in PRS and LNR tests, the current mouse learned helplessness 
findings add to the evidence that depleted NAcc DA also impairs murine motivational and learning 
processes mediating safety from punishment (Wenzel et al., 2015). Indeed, deficient motivation has 
been proposed to be one of the three major mediators of the learned helplessness effect (Maier and 
Seligman, 1976; Pryce et al., 2011), and the current evidence indicates that decreased NAcc DA 
contributes to this state. The other proposed major mediators of the learned helplessness effect are 
increased emotional responding to aversive stimuli perceived as uncontrollable, and decreased 
response-outcome expectancy (Maier and Seligman, 1976; Pryce et al., 2011). The proportion of time 
spent freezing provides a measure of emotionality in the LH paradigm: freezing was increased in 
NAcc DA depleted mice relative to control mice during IS pre-exposure but not during the escape 
test; freezing is also not increased in IS relative to ES intact mice (Pryce et al., 2012). By separating 
the escape test session into blocks of trials, we were able to analyse for learning effects on escape 
performance; both NAcc Vehicle and 6-OHDA mice made fewer escape failures as the session 
progressed, indicating that impaired operant learning did not underlie the deficit in the latter group. 
Future studies will need to ascertain whether these effects are specific to mice exposed to prior 
inescapable punishment, or whether the combination of depleted NAcc DA and escapable 
punishment also leads to motivation deficits.  
This was the only experiment in which NAcc 6-OHDA resulted in reduced DA levels in CPu; 
whilst the reduction was moderate, given the role of dorsal striatum in locomotion and motivation 
(Palmiter, 2008), it might have contributed to the behavioural effects observed. In a control 
experiment, the CPu was targeted with 6-OHDA to yield almost complete depletion of CPu DA, and 
locomotor activity was decreased, as would be expected (Kravitz et al., 2010). However, the extent of 
the activity decrease (40%) was not sufficient to suggest that the moderate off-target effects of NAcc 
6-OHDA on CPu DA would account for the observed effects in the learned helplessness test. 
Furthermore CPu DA depletion was without effect on the biomarker of body weight whereas NAcc 
DA depletion (with moderate CPu DA depletion) led to reduced body weight. Nonetheless, a future 
study of effects of targeted, moderate CPu DA depletion on behaviour in the learned helplessness 
test, and treadmill test (see below) will be needed to fully clarify whether the effects of NAcc 6-OHDA 
obtained in these tests are completely attributable to NAcc DA depletion. 
In rat, the mPFC has been demonstrated to be critical to the learning of un/controllability 
and is probably a region in which cognitive expectancy of stimulus control is processed: thus, GABA-
mediated (picrotoxin) disinhibition of mPFC resulted in increased escape behaviour in subjects 
exposed to IS (Amat et al., 2008). In the present study, there were no effects of mPFC DA depletion 
on behaviour of mice in the LH test, suggesting that DA does not modulate mPFC-mediated cognitive 
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expectancy aspects of the LH effect. These data are in accordance with the lack of effect of mPFC DA 
depletion on escape behaviour in rats exposed to IS (Ravard et al., 1990). 
The footshock treadmill test allows for the assessment of active avoidance-escape from an 
aversive stimulus under effortful conditions. NAcc 6-OHDA resulted in a marked decrease in running 
time. The majority of DA-depleted mice ran for only 1-2 minutes of the test session until receiving 
the maximum footshock amount. These data suggest that NAcc DA depletion decreased the absolute 
level of effort mice are able/motivated to exert in order to maintain safety. The findings complement 
the evidence from the learned helplessness test that NAcc DA depletion decreased motivation to 
escape footshock following IS. Whilst it is important to note that the LH and treadmill tests were 
conducted with the same mice, the majority of Vehicle mice showed typical treadmill behaviour, i.e. 
they completed the 20-min test, indicating the absence of a major confounding effect of the LH test. 
Previous studies have used the footshock treadmill test to assess various factors, including prior 
physical exercise (Massett and Berk, 2005) and inflammation (Carmichael et al., 2006). It has been 
proposed as a readout test for fatigability, a core symptom of depression (DSM-5, 2013; ICD-10, 
1994). As noted above, the current findings suggest that NAcc DA depletion acts more to reduce 
absolute effort rather than cumulative effort, to avoid-escape aversion. Given the complexity of the 
construct fatigue, both states could be components of fatigue in depression. Thus, fatigue is 
proposed to comprise muscular, motivational, motor, emotional and cognitive components 
(Demyttenaere et al., 2005; Kluger et al., 2013). It has been proposed that deficient DA modulation of 
striatal and cortical regions is important in the pathophysiology of fatigue (Demyttenaere et al., 
2005; Salamone et al., 2007). 
The third test in which effects of NAcc 6-OHDA on responsiveness to aversive stimuli were 
studied was Pavlovian fear conditioning. In contrast to the operant tests, there was no 6-OHDA effect 
on each of CS-US acquisition, context expression and CS expression, as measured using freezing 
behaviour. In rat, evidence as to whether exposure to aversive CS-US elicits increased extracellular 
DA in the NAcc is equivocal, with different findings being accommodated by proposing NAcc sub-
region specificity (Levita et al., 2002; Wilkinson et al., 1998). Excitotoxic lesioning of the rat NAcc core 
was without effect on CS-US acquisition or expression or on context-US acquisition, but did reduce 
context expression of conditioned fear (Levita et al., 2002). Therefore, the previous rat and current 
mouse findings indicate that the NAcc is not a major contributor to the mesolimbic DA regulation of 
Pavlovian fear conditioning; the amygdala is a more likely region of DA action (Pezze and Feldon, 
2004; Wenzel et al., 2015), and amygdala DA was not impacted by NAcc 6-OHDA injection. Thus, of 
the three tests in which mice were exposed to footshock, in two tests where active operant 
behaviour resulted in a reinforcing outcome NAcc DA depletion led to a deficit in behaviour, and in 
the test where behaviour was without consequence NAcc DA depletion was without effect. 
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Conclusion and Outlook 
The present study provides important novel evidence that reduced DA activity in the NAcc of 
mice leads to reduced operant responding to: a stimulus that predicts reward under effortful 
conditions; a stimulus that now predicts reward but was recently associated with non-reward; escape 
an aversive stimulus recently experienced as uncontrollable; escape an aversive stimulus under 
effortful conditions. The findings obtained with the current operant test battery extend rat evidence 
for an important NAcc DA function in the PRS test to mouse, provide the first evidence for any 
species for an important NAcc DA function in the LNR test and treadmill test, and add to the overall 
understanding of the importance of NAcc DA as a modulator of motivation under physical or 
cognitive effort relative to both rewarding and aversive stimuli (Bromberg-Martin et al., 2010; 
Salamone and Correa, 2012; Wenzel et al., 2015). This study also adds to the evidence that 
motivational and motor functions of DA, classically attributed to the VTA-mesolimbic and SNC-
nigrostriatal pathways, respectively, are intimately inter-related and can both be affected by NAcc 
DA deficiency (Haber, 2014; Sesack and Grace, 2010). Our rationale for establishing the present 
mouse test battery was to enable the integrated study of motivational processing of rewarding and 
aversive stimuli in this species. It can then be applied to investigate whether specific manipulations 
induce deficits in one or more of these processes that are of relevance to motivational domains in 
psychopathology. The evidence that NAcc DA deficiency impairs reward motivation under effortful or 
ambiguous conditions indicates its relevance to the RDoC of Positive valence systems, the core 
symptom of loss of interest in depression and the core negative symptoms in schizophrenia. The 
evidence that the same manipulation impairs aversion-conrol/safety motivation under ambiguous, 
uncontrollable or effortful conditions indicates its relevance to the RDoC of Negative valence 
systems, and the state of helplessness and the core symptom of fatigue in depression. That the 
battery enables detection of effects of a single manipulation on motivational processing of both 
reward and aversion indicates that it will facilitate the study and understanding of how reward and 
aversion processing are inter-related. We readily acknowledge that 6-OHDA DA depletion, even in a 
specific brain region, is a severe manipulation with little aetiological validity. Nonetheless, mouse 
environmental manipulations that do have aetiological validity, such as the chronic social defeat 
stressor, do indeed impact on DA signalling (Azzinnari et al., 2014; Chaudhury et al., 2013; Tanaka et 
al., 2012; Tye et al., 2013), and also lead to impaired aversion-safety motivation in the two-way 
escape and treadmill tests (Azzinnari et al., 2014), and impaired reward motivation in the PRS and 
LNR tests (Bergamini et al., unpublsihed data). The evidence that stress also alters effort-based 
decision making, biasing rats towards low effort/reward and away from high effort/reward (Shafiei et 
al., 2012), indicates that there are further important tests to be adapted for mice in translational 
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models. Future studies can combine aetiologically valid genetic and environmental manipulations 
with a reward-aversion test battery, to identify the pathophysiological processes underlying 
motivational deficits, discover novel treatment targets, and screen the preclinical therapeutic 
efficacy of compounds developed for these targets. 
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FIGURE CAPTIONS 
Figure 1. Immunohistochemical staining for tyrosine hydroxylase to delineate the extent of the 
depletion of dopaminergic fibres following (A) Vehicle or (B) 6-OHDA injection targeting the nucleus 
accumbens. Brains were perfused at day 12 post-injection. The coronal images of the mouse striata 
show depletion of tyrosine hydroxylase positive fibres in the NAcc core and shell following injection 
of 6-OHDA (B) specifically. Scale bar = 1 mm. 
Figure 2. Effects of NAcc 6-OHDA lesion (Vehicle, 1.5 ug and 2 µg 6-OHDA) on behavioural measures 
in the progressive ratio schedule test. A) Mean +/- SD cumulative scores for number of pellets earned 
at 10, 20, 30 and 40 min. * p<0.05, ** p<0.01 for 2ug 6-OHDA vs Vehicle. B) Mean +/- SD cumulative 
scores for ratio attained at 10, 20, 30 and 40 min. ** p<0.01 for 2ug 6-OHDA vs Vehicle. C) 
Scatterplot and mean for post-reinforcement pause (PRP, seconds (s)). ** p<0.01, **** p<0.0001. D) 
Absolute peak response rate (PRR). Values in parentheses indicate the ratio at which the PRR was 
achieved. * p<0.05. Significant 6-OHDA effects were obtained with ANOVA followed by Bonferonni 
post hoc testing. 
Figure 3. Effects of NAcc 6-OHDA lesion (Vehicle and 2 µg 6-OHDA) on behavioural measures in the 
spatial discrimination (SD) and learned non-reward (LNR) stages of the LNR test. A) Pre-lesion testing: 
mean+SD scores for total errors in stages SD1-3 and stages LNR1-3 prior to NAcc 6-OHDA lesion; mice 
were allocated to Vehicle and 6-OHDA groups by counter-balancing on LNR3 total-error scores. B) 
Post-NAcc 6-OHDA lesion testing: mean+SD scores in SD4 and LNR4 tests for, omissions to initiate a 
trial (OIT), incorrect choice responses (IR) and total errors (TE). * p<0.05, ** p<0.01, *** p<0.001. 
Significant 6-OHDA effects were obtained with ANOVA or unpaired t-tests. 
Figure 4. Effects of NAcc 6-OHDA lesion (Vehicle (N=13) and 2 µg 6-OHDA (N=14)) on behavioural 
measures in the learned helplessness paradigm. Data are given as scatterplot + mean. A) Activity test. 
Escape test: B) Inter-shock interval locomotor activity, C) Mean escape latency (maximum footshock 
duration = 5 s), D) Total escape failures, E) Total escape failures in blocks of 10 trials, and F) 
Footshock reactivity. In E), significant post-hoc differences between trial blocks obtained with ANOVA 
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are indicated by different letters. In F), outlier values (according to Grubbs' test) indicated with a 
were not included in the unpaired t-test. * p<0.05, *** p<0.001. 
Figure 5. Effects of NAcc 6-OHDA lesion (Vehicle (N=13) and 2 µg 6-OHDA (N=14)) on behavioural 
measures at the training and test sessions of the treadmill test. Mice were the same as those studied 
in the learned helplessness paradigm. Scatterplot and mean scores for A) Total footshock duration (s) 
in the training session, B) Running time achieved in the test session, and C) Total footshock duration 
in the test session. *** p<0.001, **** p<0.0001, obtained with unpaired t-tests. 
Figure 6. Lack of effects of NAcc 6-OHDA lesion (Vehicle and 2 µg 6-OHDA) on % time spent freezing 
(mean +/- SD) in the Pavlovian tone (CS) – footshock (US) fear conditioning paradigm. A) Freezing 
acquisition during CS-US conditioning, B) Freezing expression to context, and C) Freezing expression 
to tone CS. 
 
 
 
 
 
 
 
 
